StandardStandard

From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. / Hughes, D.; Hughes, D.A.

2002. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA, .

Allbwn ymchwil: Cyfraniad at gynhadleddPapur

HarvardHarvard

APA

Hughes, D., & Hughes, D. A. (2002). From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA, .

CBE

Hughes D, Hughes DA. 2002. From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA, .

MLA

VancouverVancouver

Hughes D, Hughes DA. From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. 2002. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA, .

Author

Hughes, D. ; Hughes, D.A. / From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA, .

RIS

TY - CONF

T1 - From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2002/5/1

Y1 - 2002/5/1

M3 - Paper

ER -